Numan raises US$60m to expand digital health services

UK digital health company Numan has raised US$60m to expand its platform, focusing on preventive care, enhanced screening and women’s health.

The funding extends Numan’s Series B round and comes after a year in which its revenue more than doubled to US$90m. The platform has now treated over 650,000 patients across obesity care, men’s health and diagnostics.

The company plans to broaden its reach into areas it says are often under-recognised or stigmatised, such as testosterone deficiency – where the body produces too little of the male hormone – and other undertreated conditions.

Founded in the UK, Numan provides digital access to clinical advice, medication, behavioural coaching, diagnostics and supplements through a single platform.

It became profitable 18 months ago and is forecasting 150 per cent growth in 2025.

Sokratis Papafloratos, chief executive of Numan, said: “We started 2025 in a very strong position, one that allowed us to be genuinely choiceful about our next move.

“Over the past 18 months we’ve seen an explosion in demand – our patients have shown incredible engagement and achieved life-changing outcomes.

“This interest fuelled our growth and success in both reaching and maintaining profitability. That’s why we believe now is the time to invest in scaling what works and innovating for the future of healthcare.”

Of the US$60m raised, US$30m is new equity led by Big Pi Ventures through its Growth Fund strategy, joined by Endeavor Catalyst, White Star Capital and Novator Partners.

The remainder includes access to US$27m in growth capital from HSBC Innovation Banking.

Nick Kalliagkopoulos, partner at Big Pi Ventures, said: “Numan has demonstrated exceptional growth and a clear vision to tackle some of healthcare’s most pressing challenges, from obesity to hormonal health.

“We are excited to back a company that combines clinical rigour with technological innovation to deliver better health outcomes.

“The team’s focus on preventative care, patient engagement, and scalable technology sets Numan apart in the digital health sector.”

The investment will support Numan’s expansion into female health, the development of screening and preventive care programmes, and further scaling of its AI-driven capabilities and infrastructure to meet rising demand.